FDA Approves ella™ for Prescription Emergency Contraception

Tagged :
Print
Text Size: Normal / Medium / Large
Printer-friendly versionPrinter-friendly version

On August 13 the U.S. Food and Drug Administration approved ella™ (ulipristal acetate) tablets for emergency contraception. The prescription-only product prevents pregnancy when taken orally within 120 hours (five days) after a contraceptive failure or unprotected intercourse.

ella is a progesterone agonist/antagonist whose likely main effect is to inhibit or delay ovulation. Since May 2009, the prescription product has been available in Europe under the brand name ellaOne.

Read the FDA press release.

Read about the opposition to ella before approval took place.

Read more details on ella on the The National Women's Health Network website.